- Report
- October 2024
- 190 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- January 2025
- 120 Pages
Global
From €2266EUR$2,490USD£1,943GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 413 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 387 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 136 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 134 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- April 2025
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- February 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2022
- 300 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- August 2022
- 117 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2023
- 118 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- April 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- August 2022
- 135 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- November 2024
- 93 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- September 2024
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP

Warfarin is a cardiovascular drug used to prevent and treat blood clots. It is an anticoagulant, meaning it helps to prevent the formation of clots in the blood vessels. Warfarin is used to treat and prevent deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to reduce the risk of stroke in people with atrial fibrillation. Warfarin is available in both generic and brand-name forms.
The Warfarin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, and Merck. Other companies include Teva Pharmaceuticals, Mylan, and Novartis. Show Less Read more